Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Amyotrophic Lateral Sclerosis"" wg kryterium: Temat


Starter badań:

Tytuł :
Short-Term Effects of Pressure Controlled Versus Volume Controlled Noninvasive Ventilation in Subjects With Amyotrophic Lateral Sclerosis.
Autorzy :
Crescimanno G; Italian National Research Council, Institute for Biomedical Research and Innovation, Palermo, Italy. .; Regional Center for Prevention and Treatment of Respiratory Complications of Rare Genetic Neuromuscular Diseases, Villa Sofia-Cervello Hospital, Palermo, Italy.
Greco F; Italian Union Against Muscular Dystrophy, branch of Palermo, Palermo, Italy.
Bertini M; Regional Center for Prevention and Treatment of Respiratory Complications of Rare Genetic Neuromuscular Diseases, Villa Sofia-Cervello Hospital, Palermo, Italy.
Arrisicato S; Regional Center for Prevention and Treatment of Respiratory Complications of Rare Genetic Neuromuscular Diseases, Villa Sofia-Cervello Hospital, Palermo, Italy.
Marrone O; Italian National Research Council, Institute for Biomedical Research and Innovation, Palermo, Italy.
Pokaż więcej
Źródło :
Respiratory care [Respir Care] 2021 Oct; Vol. 66 (10), pp. 1593-1600. Date of Electronic Publication: 2021 Aug 17.
Typ publikacji :
Journal Article
MeSH Terms :
Amyotrophic Lateral Sclerosis*/complications
Amyotrophic Lateral Sclerosis*/therapy
Noninvasive Ventilation*
Respiratory Insufficiency*
Humans ; Polysomnography ; Respiration ; Sleep
Czasopismo naukowe
Tytuł :
An open label pilot study of the safety and tolerability of perampanel in amyotrophic lateral sclerosis.
Autorzy :
Hotait M; Department of Neurology, Baylor College of Medicine, Houston, Texas, USA.
Ismail HH; Department of Neurology, American University of Beirut medical Center, Beirut, Lebanon.
Saab GE; Department of Neurology, American University of Beirut medical Center, Beirut, Lebanon.
Salameh JS; Department of Neurology, American University of Beirut medical Center, Beirut, Lebanon.
Pokaż więcej
Źródło :
Muscle & nerve [Muscle Nerve] 2021 Oct; Vol. 64 (4), pp. 504-508. Date of Electronic Publication: 2021 Aug 21.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Sleepiness*
Aggression/*drug effects
Aggression/*psychology
Amyotrophic Lateral Sclerosis/*drug therapy
Amyotrophic Lateral Sclerosis/*psychology
Nitriles/*adverse effects
Pyridones/*adverse effects
Adult ; Aged ; Amyotrophic Lateral Sclerosis/diagnosis ; Anticonvulsants/adverse effects ; Anticonvulsants/therapeutic use ; Humans ; Male ; Middle Aged ; Nitriles/therapeutic use ; Pilot Projects ; Problem Behavior/psychology ; Pyridones/therapeutic use
Czasopismo naukowe
Tytuł :
Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1 Mutant Protein Toxicity: In Vitro and In Vivo Evidences.
Autorzy :
Orienti I; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Armida M; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
Dobrowolny G; DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome, Italy.
Pepponi R; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
Sollazzini G; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
Pezzola A; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
Casola I; DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome, Italy.
Musarò A; DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome, Italy.
Popoli P; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
Potenza RL; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy. Electronic address: .
Pokaż więcej
Źródło :
Neuroscience [Neuroscience] 2021 Oct 01; Vol. 473, pp. 1-12. Date of Electronic Publication: 2021 Aug 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amyotrophic Lateral Sclerosis*/drug therapy
Amyotrophic Lateral Sclerosis*/genetics
Fenretinide*/pharmacology
Animals ; Disease Models, Animal ; Female ; Mice ; Mice, Transgenic ; Mutant Proteins ; Superoxide Dismutase/genetics ; Superoxide Dismutase-1/genetics
Czasopismo naukowe
Tytuł :
Confirmation of early non-bulbar onset of amyotrophic lateral sclerosis in Spanish league soccer players.
Autorzy :
Gamez J; Department of Neurology, GMA Clinic, European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: .
Carmona F; Department of Genetics, Microbiology and Statistics, Universitat de Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło :
Journal of the neurological sciences [J Neurol Sci] 2021 Sep 15; Vol. 428, pp. 117586. Date of Electronic Publication: 2021 Jul 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amyotrophic Lateral Sclerosis*/diagnosis
Amyotrophic Lateral Sclerosis*/epidemiology
Football*
Soccer*
Adult ; Humans ; Italy/epidemiology ; Risk Factors
Czasopismo naukowe
Tytuł :
Current Concepts on Genetic Aspects of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis.
Autorzy :
Jankovic M; Neurology Clinic, Clinical Center of Serbia, 11000 Belgrade, Serbia.; Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Novakovic I; Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Gamil Anwar Dawod P; Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.; Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University, 11591 Cairo, Egypt.
Gamil Anwar Dawod A; Internal Medicine, Hepatogastroenterology and Endoscopy Department, Faculty of Medicine, Ain Shams University, 11591 Cairo, Egypt.
Drinic A; Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Abdel Motaleb FI; Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University, 11591 Cairo, Egypt.
Ducic S; Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.; Pediatric Surgery Department, University Children's Hospital, 11000 Belgrade, Serbia.
Nikolic D; Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.; Physical Medicine and Rehabilitation Department, University Children's Hospital, Tirsova 10, 11000 Belgrade, Serbia.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Sep 11; Vol. 22 (18). Date of Electronic Publication: 2021 Sep 11.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Amyotrophic Lateral Sclerosis*/genetics
Amyotrophic Lateral Sclerosis*/metabolism
Amyotrophic Lateral Sclerosis*/pathology
Amyotrophic Lateral Sclerosis*/therapy
Mitochondria*/genetics
Mitochondria*/metabolism
Mitochondria*/pathology
Animals ; Axonal Transport/genetics ; Calcium/metabolism ; Electron Transport/genetics ; Humans ; Mitophagy/genetics ; Oxidative Phosphorylation ; Superoxide Dismutase-1/genetics ; Superoxide Dismutase-1/metabolism
Czasopismo naukowe
Tytuł :
Age at symptom onset influences cortical thinning distribution and survival in amyotrophic lateral sclerosis.
Autorzy :
Ferraro PM; Department of Neuroradiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Cabona C; Department of Neurophysiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Meo G; Department of Neurology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Rolla-Bigliani C; Department of Neuroradiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Castellan L; Department of Neuroradiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Pardini M; Department of Neurology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Inglese M; Department of Neurology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Caponnetto C; Department of Neurology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Roccatagliata L; Department of Neuroradiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Pokaż więcej
Źródło :
Neuroradiology [Neuroradiology] 2021 Sep; Vol. 63 (9), pp. 1481-1487. Date of Electronic Publication: 2021 Mar 04.
Typ publikacji :
Journal Article
MeSH Terms :
Amyotrophic Lateral Sclerosis*/diagnostic imaging
Amyotrophic Lateral Sclerosis*/pathology
Motor Cortex*/pathology
Aged ; Atrophy/pathology ; Cerebral Cortical Thinning ; Humans ; Magnetic Resonance Imaging
Czasopismo naukowe
Tytuł :
NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS.
Autorzy :
Jiménez-Villegas J; Department of Biochemistry, Medical College, Autonomous University of Madrid (UAM), Madrid, Spain; Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), Madrid, Spain; Instituto de Investigación Sanitaria La Paz (IdiPaz), Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Ferraiuolo L; Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.
Mead RJ; Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.
Shaw PJ; Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.
Cuadrado A; Department of Biochemistry, Medical College, Autonomous University of Madrid (UAM), Madrid, Spain; Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), Madrid, Spain; Instituto de Investigación Sanitaria La Paz (IdiPaz), Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Rojo AI; Department of Biochemistry, Medical College, Autonomous University of Madrid (UAM), Madrid, Spain; Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), Madrid, Spain; Instituto de Investigación Sanitaria La Paz (IdiPaz), Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Electronic address: .
Pokaż więcej
Źródło :
Free radical biology & medicine [Free Radic Biol Med] 2021 Sep; Vol. 173, pp. 125-141. Date of Electronic Publication: 2021 Jul 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Amyotrophic Lateral Sclerosis*/drug therapy
Amyotrophic Lateral Sclerosis*/genetics
NF-E2-Related Factor 2*/genetics
NF-E2-Related Factor 2*/metabolism
Antioxidants ; Gene Expression Regulation ; Humans ; Motor Neurons/metabolism
Czasopismo naukowe
Tytuł :
Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients.
Autorzy :
Milligan C; Department of Neurobiology and Anatomy, Wake Forest University, Winston-Salem, North Carolina, USA.
Atassi N; Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, Massachusetts, USA.
Babu S; Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, Massachusetts, USA.
Barohn RJ; Department of Neurology, Kansas University, Kansas City, Kansas, USA.
Caress JB; Department of Neurology, Wake Forest University, Winston-Salem, North Carolina, USA.
Cudkowicz ME; Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, Massachusetts, USA.
Evora A; Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, Massachusetts, USA.
Hawkins GA; Department of Biochemistry and Center for Precision Medicine, Wake Forest University, Winston-Salem, North Carolina, USA.
Wosiski-Kuhn M; Department of Neurobiology and Anatomy, Wake Forest University, Winston-Salem, North Carolina, USA.
Macklin EA; Department of Medicine, Biostatistics Center, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Shefner JM; Department of Neurology, Gregory W. Fulton ALS and Neuromuscular Disease Center, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
Simmons Z; Department of Neurology, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Bowser RP; Departments of Neurology and Neurobiology, Gregory W. Fulton ALS and Neuromuscular Disease Center, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
Ladha SS; Department of Neurology, Gregory W. Fulton ALS and Neuromuscular Disease Center, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
Pokaż więcej
Źródło :
Muscle & nerve [Muscle Nerve] 2021 Sep; Vol. 64 (3), pp. 309-320. Date of Electronic Publication: 2021 Jun 24.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Amyotrophic Lateral Sclerosis/*drug therapy
Anti-Inflammatory Agents/*adverse effects
Antibodies, Monoclonal, Humanized/*adverse effects
C-Reactive Protein/*metabolism
Cytokines/*metabolism
Adolescent ; Adult ; Aged ; Amyotrophic Lateral Sclerosis/blood ; Amyotrophic Lateral Sclerosis/cerebrospinal fluid ; Anti-Inflammatory Agents/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Biomarkers/blood ; Biomarkers/cerebrospinal fluid ; Cytokines/blood ; Cytokines/cerebrospinal fluid ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Aberrant cytoplasmic intron retention is a blueprint for RNA binding protein mislocalization in VCP-related amyotrophic lateral sclerosis.
Autorzy :
Tyzack GE; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Neeves J; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Crerar H; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Klein P; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Ziff O; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Taha DM; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.; Zoology Department, Faculty of Science, Alexandria University, Alexandria 21511, Egypt.
Luisier R; Genomics and Health Informatics Group, Idiap Research Institute, CH - 1920 Martigny, Switzerland.
Luscombe NM; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.; UCL Genetics Institute, University College London, London, WC1E 6BT, UK.; Okinawa Institute of Science and Technology Graduate University, Okinawa 904-0495, Japan.
Patani R; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2021 Aug 17; Vol. 144 (7), pp. 1985-1993.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amyotrophic Lateral Sclerosis*/genetics
Amyotrophic Lateral Sclerosis*/metabolism
Amyotrophic Lateral Sclerosis*/pathology
Introns*
Cytoplasm/*metabolism
RNA-Binding Proteins/*metabolism
Humans ; Mutation ; Valosin Containing Protein/genetics
Czasopismo naukowe
Tytuł :
An amyotrophic lateral sclerosis hot spot in the French Alps associated with genotoxic fungi.
Autorzy :
Lagrange E; Department of Neurology, Reference Center of Neuromuscular Disease and ALS consultations, Grenoble University Hospital, 38000 Grenoble, France.
Vernoux JP; Normandie Univ, UNICAEN, ABTE, 14000 Caen, France.
Reis J; Department of Neurology, University of Strasbourg, University Hospital of Strasbourg, Strasbourg, France; Association RISE, 3, rue du Loir, 67205 Oberhausbergen, France.
Palmer V; Department of Neurology, School of Medicine, Oregon Health and Science University, Portland, OR 97201, USA.
Camu W; ALS Reference Center, Montpellier University Hospital and University of Montpellier, Inserm UMR1051, 34000 Montpellier, France.
Spencer PS; Department of Neurology, School of Medicine, Oregon Health and Science University, Portland, OR 97201, USA; Oregon Institute of Occupational Health Sciences, Oregon Health and Science University, Portland, OR 97201, USA. Electronic address: .
Pokaż więcej
Źródło :
Journal of the neurological sciences [J Neurol Sci] 2021 Aug 15; Vol. 427, pp. 117558. Date of Electronic Publication: 2021 Jun 25.
Typ publikacji :
Journal Article
MeSH Terms :
Amyotrophic Lateral Sclerosis*/epidemiology
Amyotrophic Lateral Sclerosis*/genetics
Ascomycota ; Cohort Studies ; DNA Damage ; Fungi ; Humans
SCR Organism :
Gyromitra gigas
Czasopismo naukowe
Tytuł :
Persian adaptation of Edinburgh Cognitive and Behavioural Screen (ECAS).
Autorzy :
Mojtabavi H; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.; Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Nafissi S; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.; Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mahmoodi-Bakhtiari B; Department of Performing Arts, University of Tehran, Tehran, Iran.
Fathi D; Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Fatehi F; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.; Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło :
Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2021 Aug; Vol. 22 (5-6), pp. 426-433. Date of Electronic Publication: 2021 Feb 17.
Typ publikacji :
Journal Article
MeSH Terms :
Amyotrophic Lateral Sclerosis*/complications
Amyotrophic Lateral Sclerosis*/diagnosis
Cognition Disorders*/diagnosis
Cognition Disorders*/etiology
Cognition ; Humans ; Iran ; Language ; Neuropsychological Tests
Czasopismo naukowe
Tytuł :
Delivery of nutritional management services to people with amyotrophic lateral sclerosis (ALS).
Autorzy :
Halliday V; School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.
Zarotti N; Sheffield Institute for Translational Neuroscience (SITraN), The University of Sheffield, Sheffield, UK.
Coates E; School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.
McGeachan A; Sheffield Institute for Translational Neuroscience (SITraN), The University of Sheffield, Sheffield, UK.
Williams I; Department of Psychology, The University of Sheffield, Sheffield, UK.
White S; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Beever D; School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.
Norman P; Department of Psychology, The University of Sheffield, Sheffield, UK.
Gonzalez S; School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.
Hackney G; School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.
Ezaydi N; School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.
Stavroulakis T; Sheffield Institute for Translational Neuroscience (SITraN), The University of Sheffield, Sheffield, UK.
Bradburn M; School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.
McDermott C; Sheffield Institute for Translational Neuroscience (SITraN), The University of Sheffield, Sheffield, UK.
Pokaż więcej
Źródło :
Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2021 Aug; Vol. 22 (5-6), pp. 350-359. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amyotrophic Lateral Sclerosis*/complications
Amyotrophic Lateral Sclerosis*/therapy
Nutritional Support*
Cross-Sectional Studies ; Health Personnel ; Humans ; Nutritional Status
Czasopismo naukowe
Tytuł :
Clinical features and incidence trends of amyotrophic lateral sclerosis in Navarre, Spain, 2007-2018: a population-based study.
Autorzy :
Jericó I; Department of Neurology, Complejo Hospitalario de Navarra, IdiSNA (Navarre Institute for Health Research), Pamplona, Spain.
Elizalde-Beiras I; Department of Health Sciences, Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.; Primary Care, Servicio Navarro de Salud - Osasunbidea, IdiSNA, Pamplona, Spain.
Pagola I; Department of Neurology, Complejo Hospitalario de Navarra, IdiSNA (Navarre Institute for Health Research), Pamplona, Spain.
Torné L; Department of Neurology, Complejo Hospitalario de Navarra, IdiSNA (Navarre Institute for Health Research), Pamplona, Spain.
Galbete A; Navarrabiomed-Complejo Hospitalario de Navarra-UPNA, IdiSNA, Pamplona, Spain.; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Pamplona, Spain.
Delfrade-Osinaga J; Community Health Observatory Section, Instituto de Salud Pública y Laboral de Navarra, IdiSNA, Pamplona, Spain, and.; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Vicente E; Department of Health Sciences, Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.; Community Health Observatory Section, Instituto de Salud Pública y Laboral de Navarra, IdiSNA, Pamplona, Spain, and.
Pokaż więcej
Źródło :
Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2021 Aug; Vol. 22 (5-6), pp. 401-409. Date of Electronic Publication: 2021 Feb 27.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Amyotrophic Lateral Sclerosis*/diagnosis
Amyotrophic Lateral Sclerosis*/epidemiology
Adult ; Aged ; Delayed Diagnosis ; Female ; Humans ; Incidence ; Middle Aged ; Retrospective Studies ; Spain/epidemiology
Czasopismo naukowe
Tytuł :
The utility of ALS staging systems in a multi-ethnic patient cohort.
Autorzy :
Abdul Aziz NA; Neurology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Toh TH; Neurology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Loh EC; Palliative Care Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia and.
Capelle DP; Palliative Care Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia and.
Goh KJ; Neurology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Abdul Latif L; Department of Rehabilitation Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Chung TY; Department of Rehabilitation Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Shahrizaila N; Neurology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Pokaż więcej
Źródło :
Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2021 Aug; Vol. 22 (5-6), pp. 341-349. Date of Electronic Publication: 2021 Mar 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amyotrophic Lateral Sclerosis*/diagnosis
Amyotrophic Lateral Sclerosis*/ethnology
Cohort Studies ; Disease Progression ; Humans ; Prospective Studies
Czasopismo naukowe
Tytuł :
Prove pathogenicity of OPTN variants before establishing a causal relation with amyotrophic lateral sclerosis.
Autorzy :
Finsterer J; Klinik Landstrasse, Messerli Institute, Vienna, Austria. Electronic address: .
Scorza FA; Disciplina de Neurociência, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, Brazil.
Scorza CA; Disciplina de Neurociência, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, Brazil.
Fiorini AC; Programa de Estudos Pós-Graduado em Fonoaudiologia, Pontifícia Universidade Católica de São Paulo (PUC-SP), Brazil; Departamento de Fonoaudiologia, Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil.
Pokaż więcej
Źródło :
Neurobiology of aging [Neurobiol Aging] 2021 Oct; Vol. 106, pp. 357. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji :
Letter; Comment
MeSH Terms :
Amyotrophic Lateral Sclerosis*/genetics
Cell Cycle Proteins ; Humans ; Transcription Factor TFIIIA ; Virulence
Opinia redakcyjna
Tytuł :
Establishment of chemically oligomerizable TAR DNA-binding protein-43 which mimics amyotrophic lateral sclerosis pathology in mammalian cells.
Autorzy :
Yamanaka Y; Department of Molecular Pathology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan.
Miyagi T; Department of Molecular Pathology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan.
Harada Y; Department of Molecular Pathology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan.
Kuroda M; Department of Molecular Pathology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan. .
Kanekura K; Department of Molecular Pathology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan. .
Pokaż więcej
Źródło :
Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2021 Oct; Vol. 101 (10), pp. 1331-1340. Date of Electronic Publication: 2021 Jun 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amyotrophic Lateral Sclerosis*/metabolism
Amyotrophic Lateral Sclerosis*/pathology
DNA-Binding Proteins*/chemistry
DNA-Binding Proteins*/genetics
DNA-Binding Proteins*/metabolism
HEK293 Cells ; HeLa Cells ; Humans
Czasopismo naukowe
Tytuł :
Physician-hastened death in California for patients with amyotrophic lateral sclerosis: Part of a bigger picture.
Autorzy :
Grogan J; Department of Neurology, Penn State University, Hershey, Pennsylvania, USA.
Simmons Z; Department of Neurology, Penn State University, Hershey, Pennsylvania, USA.
Pokaż więcej
Źródło :
Muscle & nerve [Muscle Nerve] 2021 Oct; Vol. 64 (4), pp. 381-384. Date of Electronic Publication: 2021 Aug 26.
Typ publikacji :
Editorial
MeSH Terms :
Physician's Role*
Amyotrophic Lateral Sclerosis/*epidemiology
Amyotrophic Lateral Sclerosis/*therapy
Suicide, Assisted/*legislation & jurisprudence
Amyotrophic Lateral Sclerosis/diagnosis ; California/epidemiology ; Humans ; Terminal Care/legislation & jurisprudence ; Terminal Care/methods
Opinia redakcyjna
Tytuł :
ALS patient and caregiver attitudes toward physician-hastened death in California.
Autorzy :
Hauswirth AG; University of California, San Francisco, School of Medicine, San Francisco, California, USA.; Internal Medicine Department, Kaiser San Francisco, San Francisco, California, USA.
George HC; Department of Neurology, University of California, San Francisco, San Francisco, California, USA.
Lomen-Hoerth C; Department of Neurology, University of California, San Francisco, San Francisco, California, USA.
Pokaż więcej
Źródło :
Muscle & nerve [Muscle Nerve] 2021 Oct; Vol. 64 (4), pp. 428-434. Date of Electronic Publication: 2021 Jun 12.
Typ publikacji :
Journal Article
MeSH Terms :
Health Knowledge, Attitudes, Practice*
Amyotrophic Lateral Sclerosis/*psychology
Caregivers/*psychology
Patient Participation/*psychology
Physician's Role/*psychology
Suicide, Assisted/*psychology
Adaptation, Psychological/physiology ; Adult ; Aged ; Aged, 80 and over ; Amyotrophic Lateral Sclerosis/epidemiology ; Amyotrophic Lateral Sclerosis/therapy ; California/epidemiology ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Patient Participation/methods
Czasopismo naukowe
Tytuł :
Altered stress granule disassembly: links to neurodegenerative disease?
Autorzy :
Dubinski A; Department of Neurosciences, Université de Montréal & Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Vande Velde C; Department of Neurosciences, Université de Montréal & Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada. Electronic address: .
Pokaż więcej
Źródło :
Trends in neurosciences [Trends Neurosci] 2021 Oct; Vol. 44 (10), pp. 765-766. Date of Electronic Publication: 2021 Aug 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amyotrophic Lateral Sclerosis*
Neurodegenerative Diseases*
DNA Helicases/metabolism ; Humans ; Poly-ADP-Ribose Binding Proteins ; RNA Helicases/metabolism ; RNA Recognition Motif Proteins
Czasopismo naukowe
Tytuł :
Continuing Non-Invasive Ventilation During Amyotrophic Lateral Sclerosis-Related Hospice Care Is Medically, Administratively, and Financially Feasible.
Autorzy :
Choi PJ; Division of Pulmonary and Critical Care, Department of Internal Medicine, 1259University of Michigan, Ann Arbor, MI, USA.
Murn M; Division of Pulmonary and Critical Care, Department of Internal Medicine, 5798Columbia University, New York, NY, USA.
Turner R; Department of Internal Medicine, 3065Duke University Medical Center, Section of Palliative Medicine, Durham, NC, USA.
Bedlack R; Department of Neurology, 3065Duke University Medical Center, Durham, NC, USA.
Pokaż więcej
Źródło :
The American journal of hospice & palliative care [Am J Hosp Palliat Care] 2021 Oct; Vol. 38 (10), pp. 1238-1241. Date of Electronic Publication: 2020 Dec 17.
Typ publikacji :
Journal Article
MeSH Terms :
Amyotrophic Lateral Sclerosis*/therapy
Hospice Care*
Noninvasive Ventilation*
Respiratory Insufficiency*/therapy
Cross-Sectional Studies ; Humans ; Retrospective Studies ; Time Factors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies